1 IPROVE Innovation Partnership for a Roadmapon VaccinesinEurope
2 IPROVE IN BRIEF What is IPROVE? Whydo we need IPROVE? IPROVE in actions (How?) Partnership (Who?)
3 WHAT An EU project (FP7) financed by the European Commission and running for 2-years from December 2013 to November 2015, budget of EUR 496,000 (Coordination & Support Action) Four leading European organisation in the vaccine field: Vaccines Europe (VE/EFPIA) European Vaccine Initiative (EVI) Sclavo Vaccines Association (SVA) European Infrastructure for Translational Medicine (EATRIS) Goal: Establish a coordinated and comprehensive European vision on gaps, needs, and priorities to spur vaccine innovation in Europe, analysing the entire value chain implementing a joined-up participatory stakeholder consultation process (TOOL). Deliverable: ROADMAP
4 WHY Europe s traditional lead in the vaccine sector in decline Traditional R&D model becoming the less and less viable and need to put in place the appropriate push and pull mechanisms to drive innovation Disparate and uncoordinated R&D agendas and need to breakdown silos in the EU vaccine R&D landscape, mobilise and pool the available yet fragmented expertise across centres of excellence and foster the establishment of vaccine innovation agenda: Consensus on priority R&D and technologies to address unmet needs Efficiency & effectiveness of funding at EU & Member State level Framework conditions needed (political, financial, regulatory) Efficiency & effectiveness of funding at EU & Member State level Need to maintain traditional EU leadership in the sector vs. other regions
5 GOAL Produce through a bottom-up approach a strategic plan shaped as a roadmap that gives clear vision, direction and impetus to policy-makers, public and private funders/investors, programming bodies at both EU and national level Translate into Policies Programmes Funding instruments Projects Novel models of collaboration
6 HOW Governance European Commission (DG R&I) Steering Committee (1 rep from each partner) Coordinator (Vaccines Europe) Affiliated members (stakeholders) Advisory Board (5 independent experts) WP1 Management & coordination WP2 Identification stakeholders and activities WP3 Consultation WP4 European strategic roadmap WP5 Communication & dissemination
7 HOW HOW Work Governance Plan (WPs)
8 HOW Consultation Pillars (WP3) Vaccine SMEs needs (May 2014) 2. Training & Communications (October 2014) 3. Infrastructures and structural needs (December 2014) 4. Innovation in R&D, Production, and Delivery (January 2015) 5. Therapeutic vaccines (March 2015) FINAL IPROVE ROADMAP (September 2015)
9 Contacts Karam Adel Ali Vaccines Europe Project Coordinator Florence Bietrix EATRIS Communications leader
10 Thank You
11 Acknowledgment This project has received funding from the European Union s Seventh Framework Programme for research, technological development and demonstration under grant agreement no
12 WHO (1/4) VE is a specialised vaccine industry group operating within the European Federation of Pharmaceutical Industries and Association (EFPIA), hereinafter referred to as VE/EFPIA. VE/EFPIA represents all the major research-based global vaccine companies as well as small and medium-sized enterprises operating in Europe. Companies represented are involved in research and development (R&D), clinical trials, production and marketing of vaccines VE/EFPIA aims to: foster a favorable policy climate for the vaccine industry in Europe to facilitate availability and access to new and innovative vaccines worldwide; create a supportive environment for improved vaccine protection, innovative vaccine development and improved coverage throughout life in the interest of individuals and community; support vaccine R&D through innovative vaccine applications.
13 WHO (2/4) Leading European Product Development Partnership (PDP) supporting the development of effective, accessible, and affordable vaccines against diseases of poverty. EVI contributes to the global efforts to control these diseases in three main ways: by providing financial, operational and managerial support to the development and clinical assessment of vaccine candidates; by promoting affordability and accessibility of vaccines in low-income populations; and by aligning all major stakeholders to ensure the successful development of vaccines for diseases of poverty for low-income populations. EVI is the coordinator of TRANSVAC (www.transvac.org), the FP7 pan-european vaccine infrastructure project.
14 WHO (3/4) SVA is a non-profit association whose main objective is scientific research targeted towards the discovery and study of advanced immunization technologies with the aim of contributing to the innovative development of safe, effective prophylactic and therapeutic vaccines. SVA members represent European leading research organisations. SVA is the coordinator ADITEC (www.aditecproject.org), the High Impact collaborative FP7 research program that aims to accelerate the development of novel and powerful immunization technologies for the next generation of human vaccines.
15 WHO (4/4) EATRIS is an ERIC (European Research Infrastructure Consortium) since December It is composed of 69 academic institutions of excellence in translational research The EATRIS vaccines platform provides the critical expertise and infrastructure in translational vaccinology to advance candidates up to phase IIa trials. It includes 10 centers of excellence in the vaccines field.
Italian Presidency of the Council of the European Union italia0.eu A VISION TOWARDS A NEW RENAISSANCE ACT LEADING ENABLING TECHNOLOGIES FOR SOCIETAL CHALLENGES Recommendations This conference has received
EN ANNEX 4 " ANNEX 4 HORIZON 2020 WORK PROGRAMME 2016 2017 4..." This draft text is submitted to the Horizon 2020 Programme Committee as the basis for an exchange of views. The text is still subject to
For Public Consultation Version 4 March 2014 ESPON 2020 Cooperation Programme DRAFT Notification to Readers: The structure of this version of the Draft ESPON Cooperation Programme is based on the European
EUROPEAN COMMISSION Brussels, XXX COM(2011) 811/3 Proposal for a COUNCIL DECISION establishing the Specific Programme Implementing Horizon 2020 - The Framework Programme for Research and Innovation (2014-2020)
INTERREG EUROPE 2014-2020 CCI 2014 TC 16 RFIR 001 Cooperation Programme document Final 07 May 2014 Based on the Model for cooperation programmes under the European territorial cooperation goal as established
Evaluation of Pertinence and Impact of Research Infrastructure Activity in FP7 - EPIRIA FINAL REPORT A study prepared for the European Commission DG Communications Networks, Content & Technology by: in
Draft Horizon 2020 Work Programme 2014-2015 In the area Important notice: This paper is made public just before the adoption process of the work programme to provide potential participants with the currently
EN HORIZON 2020 WORK PROGRAMME 2014 2015 4. Revised This Work Programme was adopted on 10 December 2013. The parts that relate to 2015 (topics, dates, budget) have, with this revised version, been updated.
EUROPEAN COMMISSION Brussels, 2.7.2014 SWD(2014) 214 final COMMISSION STAFF WORKING DOCUMENT Report on the Implementation of the Communication 'Unleashing the Potential of Cloud Computing in Europe' Accompanying
Position Paper October 2012 Response to the Commission consultation on the Enterprise Europe Network THE CHAMBERS The Association of European Chambers of Commerce and Industry Av. des Arts 19 A/D ; B-1000
URBACT III OPERATIONAL PROGRAMME (2014-2020) CALL FOR PROPOSALS FOR THE CREATION OF 20 ACTION-PLANNING NETWORKS Open 30 March 2015 16 June 2015 1 TABLE OF CONTENT INTRODUCTION... 3 SECTION 1 - ABOUT URBACT
HORIZON 2020 WORK PROGRAMME 2014 2015 6. Important Notice on the First Horizon 2020 Work Programme This Work Programme covers 2014 and 2015. Due to the launching phase of Horizon 2020, parts of the Work
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 28.5.2002 COM(2002) 263 final COMMUNICATION FROM THE COMMISSION TO THE COUNCIL, THE EUROPEAN PARLIAMENT, THE ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE
Guidance document on programme development and implementation for the Ten Year Framework of Programmes on Sustainable Consumption and Production (10YFP): Criteria, structure and steps to develop and operationalize
Report of the Research Prioritisation Steering Group REPORT OF THE RESEARCH PRIORITISATION STEERING GROUP Minister s Foreword The last decade has seen consistent and considerable public and private investment
EUROPEAN COMMISSION Employment, Social Affairs and Inclusion DG Europe 2020: Employment Policies Skills, Mobility and Employment Services BUDGET HEADING 04 03 02 01 EaSI - PROGRESS European Sector Skills
GOOD PLACES, BETTER HEALTH A NEW APPROACH TO ENVIRONMENT AND HEALTH IN SCOTLAND IMPLEMENTATION PLAN GOOD PLACES, BETTER HEALTH A NEW APPROACH TO ENVIRONMENT AND HEALTH IN SCOTLAND IMPLEMENTATION PLAN The
15.3.2014 EN Official Journal of the European Union L 77/11 REGULATION (EU) No 231/2014 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 11 March 2014 establishing an Instrument for Pre-accession Assistance
EN HORIZON 2020 WORK PROGRAMME 2014 2015 16. Revised This Work Programme was adopted on 10 December 2013. The parts that relate to 2015 (topics, dates, budget) have, with this revised version, been updated.
2011-2016 Strategic Plan Creating a healthier world through bold innovation 2011-2016 STRATEGIC PLAN Table of contents I. Global direction 1 Mission and vision statements 2 Guiding principles 3 Organizational
WORK PROGRAMME FOR GRANTS 2015 of the European Union represented by the European Commission, DG NEAR, Regional Cooperation and Programmes Unit Agreement with the European Investment Bank for the management
DRAFT COOPERATION PROGRAMME INTERREG VB NORTH WEST EUROPE 2014-2020 FOR PUBLIC CONSULTATION (Draft version 4 March 2014) INDEX SECTION 1. Strategy for the cooperation programme... 3 1.1 Strategy for the
EUROPEAN COMMISSION Employment, Social Affairs and Equal Opportunities DG Directorate-General General Coordination, Interinstitutional Relations Brussels, 21 December 2006 01/FB D(2006) PROGRESS/003/2006